175 related articles for article (PubMed ID: 18542844)
1. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
Podhajcer OL; Benedetti LG; Girotti MR; Prada F; Salvatierra E; Llera AS
Cancer Metastasis Rev; 2008 Dec; 27(4):691-705. PubMed ID: 18542844
[TBL] [Abstract][Full Text] [Related]
2. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
Podhajcer OL; Benedetti L; Girotti MR; Prada F; Salvatierra E; Llera AS
Cancer Metastasis Rev; 2008 Sep; 27(3):523-37. PubMed ID: 18459035
[TBL] [Abstract][Full Text] [Related]
3. SPARC in cancer biology: its role in cancer progression and potential for therapy.
Tai IT; Tang MJ
Drug Resist Updat; 2008 Dec; 11(6):231-46. PubMed ID: 18849185
[TBL] [Abstract][Full Text] [Related]
4. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
Clark CJ; Sage EH
J Cell Biochem; 2008 Jun; 104(3):721-32. PubMed ID: 18253934
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
6. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
7. Modulation of matrix remodeling by SPARC in neoplastic progression.
Chlenski A; Cohn SL
Semin Cell Dev Biol; 2010 Feb; 21(1):55-65. PubMed ID: 19958839
[TBL] [Abstract][Full Text] [Related]
8. SPARC and tumor growth: where the seed meets the soil?
Framson PE; Sage EH
J Cell Biochem; 2004 Jul; 92(4):679-90. PubMed ID: 15211566
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
10. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
12. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
13. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
15. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
16. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
18. Expression of SPARC/osteonectin/BM4O in the human gut: predominance in the stroma of the remodeling distal intestine.
Lussier C; Sodek J; Beaulieu JF
J Cell Biochem; 2001; 81(3):463-76. PubMed ID: 11255229
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix.
Gooden MD; Vernon RB; Bassuk JA; Sage EH
J Cell Biochem; 1999 Aug; 74(2):152-67. PubMed ID: 10404386
[TBL] [Abstract][Full Text] [Related]
20. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
